Gillison, M., Awad, M., Twardowski, P., Sukari, A., Johnson, M., Lackner, R., Stein, M., DeCillis, A., Hernandez, R., Price, J., Mancini, K., Shainheit, M., Santone, G., Shukor, S., Bicak, E., Vemulapalli, V., Tjon, E., Flechtner, J., Davis, T., & Cohen, R. (2021). 485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors. Regular and Young Investigator Award Abstracts, A515–A515. https://doi.org/10.1136/jitc-2021-sitc2021.485